Henry Schein news
The WiseView Research desk's stories that name Henry Schein, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The HSIC page →
- HeadlineAnalysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for
- HeadlineHenry Schein to Report Q3 Earnings: Here's What You Should Know
- HeadlineHenry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET
- HeadlineWhy Henry Schein (HSIC) is a Top Growth Stock for the Long-Term
- HeadlineHenry Schein (HSIC) is a Top-Ranked Value Stock: Should You Buy?
- HeadlineHenry Schein Announces Chief Financial Officer Leadership Transition
- HeadlineHSIC or MMSI: Which Is the Better Value Stock Right Now?
- HeadlineShould Value Investors Buy Henry Schein (HSIC) Stock?
- HeadlineHenry Schein Cares Marks 25 Years of Helping Health Happen®
- CongressMichael McCaul sold $1,001 - $15,000 of HSIC
- CongressMichael McCaul sold $15,001 - $50,000 of HSIC
- CongressJulie Johnson sold $1,001 - $15,000 of HSIC
- CongressRob Bresnahan bought $1,001 - $15,000 of HSIC
- CongressGilbert Cisneros sold $1,001 - $15,000 of HSIC
- CongressRo Khanna bought $1,001 - $15,000 of HSIC
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.